Catheter Precision (VTAK) announced receipt of a VIVO purchase order from University Clinical Center Ljubljana, a hospital in Slovenia. This expands Catheter Precision’s global sales footprint to 15 countries. “We are thrilled that we are growing our global sales footprint and now have products in 15 countries,” said David Jenkins, CEO of Catheter Precision. “Continued expansion validates that our products, both VIVO and LockeT, provide benefits to physicians by solving real-world challenges in EP Lab workflows and that physicians are finding our products are easy to use and effective for streamlining EP procedures and recovery after the procedures.”
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VTAK:
- Catheter Precision Extends Insider Short-Term Debt Maturities
- Catheter Precision announces expansion of LockeT into eight European country
- Catheter Precision secures tender from leading hospital in Hungary
- Catheter Precision announces launch of LockeT in Switzerland
- Catheter Precision announces addition of key ablation procedures to ASC by CMS
